查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513618

药物滥用检测服务市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2033年

Drug of Abuse Testing Services Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球药物滥用检测服务市场的综合报告。该报告全面评估了主要市场动态，包括驱动因素、趋势、机会和挑战，并提供了有关市场结构的详细见解。

关键见解

  • 药物滥用检测服务的市场规模（2024 年）：32 亿美元
  • 预计市值（2033 年）：51 亿美元
  • 全球市场成长率（2023-2033 年复合年增长率）：5.4%：5.4%

药物滥用检测服务市场 - 研究范围：

药物滥用检测服务在识别和管理药物滥用问题、确保工作场所安全以及支持法律和医疗目标方面发挥着重要作用。这些服务包括各种测试方法，包括尿液测试、头髮测试、唾液测试和血液测试，以检测是否有非法和受管制物质。该市场为医院、诊断实验室、执法机构和工作场所筛检计画提供服务，提供各种检测解决方案和技术。

推动市场成长的因素：

全球药物滥用检测服务市场由药物滥用盛行、严格的政府法规以及工作场所药物检测需求不断增长等几个关键因素推动。人们越来越认识到药物滥用对健康和生产力的负面影响，这推动了对有效检测解决方案的需求。快速准确检测方法的开发等技术进步正在提高药物检测服务的效率和可靠性，进一步推动市场成长。此外，新兴国家检测服务的扩展和数位健康平台的整合正在为市场参与者创造新的机会。

市场限制因素：

儘管成长前景广阔，但药物滥用检测服务市场仍面临隐私问题、监管合规性和先进检测技术的高成本等挑战。有关药物测试性能和报告的严格规定给服务提供者带来了合规负担，影响了市场进入障碍和营运成本。此外，药物检测结果可能出现假阳性和假阴性，这对检测服务的可靠性和可接受性构成了挑战。解决这些监管和技术障碍需要持续投资研发、与监管机构合作以及实施强有力的品质控制措施。

市场机会：

由于技术创新、不断发展的医疗保健政策以及扩大采用远距医疗服务，药物滥用检测服务市场提供了巨大的成长机会。人工智慧、机器学习等先进技术的融合，提高了药物检测过程的准确性和效率。扩大药物检测服务在疼痛管理、心理健康治疗和运动兴奋剂控制方面的应用，扩大市场范围并刺激创新。策略合作伙伴关係、研发投资以及引入具有成本效益的检测解决方案对于利用新机会并保持在动态滥用药物检测市场中的领导地位至关重要。

本报告解决的关键问题

  • 推动药物滥用检测服务市场全球成长的关键因素有哪些？
  • 哪些测试方法和应用程式正在推动不同产业采用药物测试服务？
  • 技术进步如何改变药物滥用检测服务市场的竞争格局？
  • 谁是药物滥用检测服务市场的主要参与者？ 他们采取哪些策略来维持市场地位？
  • 全球药物滥用检测服务市场的新趋势和未来前景是什么？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 市场背景

  • 市场动态
  • 情势预测
  • 机会地图分析
  • 产品生命週期分析
  • 投资可行性矩阵
  • PESTLE和波特五力分析
  • 法规情形
  • 各地区的亲市场预测

第4章 全球药物滥用检测服务市场分析

  • 过去的市场规模金额(10亿美元)分析，2019年～2023年
  • 现在及未来市场规模金额(10亿美元)预测，2024年～2033年
    • 前一年同期比较成长趋势分析
    • 绝对额的机会分析

第五章药物滥用检测服务的全球市场分析：药物类型

  • 简介/主要发现
  • 2019-2023 年药物类型划分的过去市场规模与价值（十亿美元）分析
  • 2024-2033 年药物类型划分的当前和未来市场规模价值（十亿美元）分析和预测
    • 酒精
    • 大麻/大麻
    • 可卡因
    • 阿片类药物
    • 安非他明/甲基安非他明
    • LSD
    • 其他药物类型
  • 年成长趋势分析：依药物类型划分，2019-2023 年
  • 绝对价值机会分析：依药物类型，2024-2033 年

第6章 全球药物滥用检测服务市场分析:各地区

  • 简介
  • 过去的市场规模金额(10亿美元)的分析:各地区，2019年～2023年
  • 目前市场规模金额(10亿美元)的分析与预测:各地区，2024年～2033年
    • 北美
    • 南美
    • 欧洲
    • 亚太地区
    • 中东·非洲
  • 市场魅力分析:各地区

第7章 北美的药物滥用检测服务市场分析(各国)

第8章 南美的药物滥用检测服务市场分析(各国)

第9章 欧洲的药物滥用检测服务市场分析(各国)

第10章 亚太地区的药物滥用检测服务市场分析(各国)

第11章 中东·非洲的药物滥用检测服务市场分析(各国)

第12章 主要国家的药物滥用检测服务市场分析

  • 美国
  • 加拿大
  • 巴西
  • 墨西哥
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 俄罗斯
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 以色列

第13章 市场结构分析

  • 竞争仪表板
  • 竞争基准
  • 主要企业的市场占有率分析

第14章 竞争分析

  • 竞争的详细资讯
    • Quest Diagnostics, Inc.
    • Abbott Laboratories
    • Clinical Reference Laboratory, Inc.
    • Laboratory Corporation of America Holdings
    • Cordant Health Solutions
    • Legacy Medical Services, LLC.
    • DrugScan
    • Omega Laboratories, Inc.
    • Psychemedics Corporation
    • Mayo Clinic Laboratories

第15章 所使用的前提条件与缩写

第16章 调查手法

简介目录
Product Code: PMRREP33256

Persistence Market Research has recently released a comprehensive report on the worldwide market for drug of abuse testing services. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Drug of Abuse Testing Services Market Size (2024E): USD 3.2 Billion
  • Projected Market Value (2033F): USD 5.1 Billion
  • Global Market Growth Rate (CAGR 2023 to 2033): 5.4%

Drug of Abuse Testing Services Market - Report Scope:

Drug of abuse testing services play a crucial role in identifying and managing substance abuse issues, ensuring workplace safety, and supporting legal and medical purposes. These services encompass various testing methods, including urine, hair, saliva, and blood tests, to detect the presence of illicit drugs and controlled substances. The market caters to hospitals, diagnostic laboratories, law enforcement agencies, and workplace screening programs, offering a range of testing solutions and technologies.

Market Growth Drivers:

The global drug of abuse testing services market is propelled by several key factors, including the increasing prevalence of substance abuse, stringent government regulations, and the rising demand for workplace drug testing. The growing awareness about the adverse effects of drug abuse on health and productivity drives the need for effective testing solutions. Technological advancements, such as the development of rapid and accurate testing methods, enhance the efficiency and reliability of drug testing services, further fueling market growth. Moreover, the expansion of testing services in emerging economies and the integration of digital health platforms create new opportunities for market players.

Market Restraints:

Despite promising growth prospects, the drug of abuse testing services market faces challenges related to privacy concerns, regulatory compliance, and the high cost of advanced testing technologies. Stringent regulations governing the conduct and reporting of drug tests impose compliance burdens on service providers, affecting market entry barriers and operational costs. Additionally, the potential for false positives and negatives in drug testing results poses challenges for the credibility and acceptance of testing services. Addressing these regulatory and technical barriers requires continuous investment in research and development, collaboration with regulatory bodies, and the implementation of robust quality control measures.

Market Opportunities:

The drug of abuse testing services market presents significant growth opportunities driven by technological innovations, evolving healthcare policies, and the increasing adoption of telehealth services. The integration of advanced technologies, such as artificial intelligence and machine learning, improves the accuracy and efficiency of drug testing processes. The expanding application of drug testing services in pain management, mental health treatment, and sports doping control broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of cost-effective testing solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic drug of abuse testing landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the drug of abuse testing services market globally?
  • Which testing methods and applications are driving the adoption of drug testing services across different sectors?
  • How are technological advancements reshaping the competitive landscape of the drug of abuse testing services market?
  • Who are the key players contributing to the drug of abuse testing services market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global drug of abuse testing services market?

Competitive Intelligence and Business Strategy:

Leading players in the global drug of abuse testing services market, including Abbott Laboratories, Quest Diagnostics, and LabCorp, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced testing solutions, including rapid test kits, automated analyzers, and digital platforms, catering to diverse client needs and regulatory requirements. Collaborations with healthcare providers, employers, and law enforcement agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and client education fosters market growth and enhances service reliability in the rapidly evolving drug of abuse testing landscape.

Key Companies Profiled:

  • Quest Diagnostics
  • Abbott Laboratories
  • Cordant Health Solutions
  • Omega Laboratories
  • Mayo Clinic Laboratories
  • Air Methods
  • ALPHASTAR
  • Clinical Reference Laboratory, Inc.
  • Laboratory Corporation of America Holdings
  • Cordant Health Solutions
  • Legacy Medical Services, LLC
  • DrugScan
  • Psychemedics Corporation

Market Segments Covered in Drug of Abuse Testing Services Market Analysis

By Drug Type

  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Product Life Cycle Analysis
  • 3.5. Investment Feasibility Matrix
  • 3.6. PESTLE and Porter's Analysis
  • 3.7. Regulatory Landscape
    • 3.7.1. By Key Regions
    • 3.7.2. By Key Countries
  • 3.8. Regional Parent Market Outlook

4. Global Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast, 2024-2033

  • 4.1. Historical Market Size Value (US$ Bn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2024-2033
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Drug Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Bn) Analysis By Drug Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Drug Type, 2024-2033
    • 5.3.1. Alcohol
    • 5.3.2. Cannabis/Marijuana
    • 5.3.3. Cocaine
    • 5.3.4. Opioids
    • 5.3.5. Amphetamine & Methamphetamine
    • 5.3.6. LSD
    • 5.3.7. Other Drug Types
  • 5.4. Y-o-Y Growth Trend Analysis By Drug Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Drug Type, 2024-2033

6. Global Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 6.1. Introduction
  • 6.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2019-2023
  • 6.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 6.3.1. North America
    • 6.3.2. Latin America
    • 6.3.3. Europe
    • 6.3.4. Asia Pacific
    • 6.3.5. Middle East and Africa
  • 6.4. Market Attractiveness Analysis By Region

7. North America Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 7.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 7.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 7.2.1. By Country
      • 7.2.1.1. U.S.
      • 7.2.1.2. Canada
    • 7.2.2. By Drug Type
  • 7.3. Market Attractiveness Analysis
    • 7.3.1. By Country
    • 7.3.2. By Drug Type
  • 7.4. Key Takeaways

8. Latin America Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 8.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 8.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 8.2.1. By Country
      • 8.2.1.1. Brazil
      • 8.2.1.2. Mexico
      • 8.2.1.3. Rest of Latin America
    • 8.2.2. By Drug Type
  • 8.3. Market Attractiveness Analysis
    • 8.3.1. By Country
    • 8.3.2. By Drug Type
  • 8.4. Key Takeaways

9. Europe Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 9.2.1. By Country
      • 9.2.1.1. Germany
      • 9.2.1.2. U.K.
      • 9.2.1.3. France
      • 9.2.1.4. Spain
      • 9.2.1.5. Italy
      • 9.2.1.6. Russia
      • 9.2.1.7. Rest of Europe
    • 9.2.2. By Drug Type
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Drug Type
  • 9.4. Key Takeaways

10. Asia Pacific Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 10.2.1. By Country
      • 10.2.1.1. China
      • 10.2.1.2. Japan
      • 10.2.1.3. India
      • 10.2.1.4. South Korea
      • 10.2.1.5. Australia
      • 10.2.1.6. Rest of APAC
    • 10.2.2. By Drug Type
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Drug Type
  • 10.4. Key Takeaways

11. Middle East and Africa Drug of Abuse Testing Services Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 11.2.1. By Country
      • 11.2.1.1. South Africa
      • 11.2.1.2. Saudi Arabia
      • 11.2.1.3. UAE
      • 11.2.1.4. Israel
      • 11.2.1.5. Rest of MEA
    • 11.2.2. By Drug Type
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Drug Type
  • 11.4. Key Takeaways

12. Key Countries Drug of Abuse Testing Services Market Analysis

  • 12.1. U.S.
    • 12.1.1. Pricing Analysis
    • 12.1.2. Market Share Analysis, 2024
      • 12.1.2.1. By Drug Type
  • 12.2. Canada
    • 12.2.1. Pricing Analysis
    • 12.2.2. Market Share Analysis, 2024
      • 12.2.2.1. By Drug Type
  • 12.3. Brazil
    • 12.3.1. Pricing Analysis
    • 12.3.2. Market Share Analysis, 2024
      • 12.3.2.1. By Drug Type
  • 12.4. Mexico
    • 12.4.1. Pricing Analysis
    • 12.4.2. Market Share Analysis, 2024
      • 12.4.2.1. By Drug Type
  • 12.5. Germany
    • 12.5.1. Pricing Analysis
    • 12.5.2. Market Share Analysis, 2024
      • 12.5.2.1. By Drug Type
  • 12.6. U.K.
    • 12.6.1. Pricing Analysis
    • 12.6.2. Market Share Analysis, 2024
      • 12.6.2.1. By Drug Type
  • 12.7. France
    • 12.7.1. Pricing Analysis
    • 12.7.2. Market Share Analysis, 2024
      • 12.7.2.1. By Drug Type
  • 12.8. Spain
    • 12.8.1. Pricing Analysis
    • 12.8.2. Market Share Analysis, 2024
      • 12.8.2.1. By Drug Type
  • 12.9. Italy
    • 12.9.1. Pricing Analysis
    • 12.9.2. Market Share Analysis, 2024
      • 12.9.2.1. By Drug Type
  • 12.10. Russia
    • 12.10.1. Pricing Analysis
    • 12.10.2. Market Share Analysis, 2024
      • 12.10.2.1. By Drug Type
  • 12.11. China
    • 12.11.1. Pricing Analysis
    • 12.11.2. Market Share Analysis, 2024
      • 12.11.2.1. By Drug Type
  • 12.12. Japan
    • 12.12.1. Pricing Analysis
    • 12.12.2. Market Share Analysis, 2024
      • 12.12.2.1. By Drug Type
  • 12.13. India
    • 12.13.1. Pricing Analysis
    • 12.13.2. Market Share Analysis, 2024
      • 12.13.2.1. By Drug Type
  • 12.14. South Korea
    • 12.14.1. Pricing Analysis
    • 12.14.2. Market Share Analysis, 2024
      • 12.14.2.1. By Drug Type
  • 12.15. Australia
    • 12.15.1. Pricing Analysis
    • 12.15.2. Market Share Analysis, 2024
      • 12.15.2.1. By Drug Type
  • 12.16. South Africa
    • 12.16.1. Pricing Analysis
    • 12.16.2. Market Share Analysis, 2024
      • 12.16.2.1. By Drug Type
  • 12.17. Saudi Arabia
    • 12.17.1. Pricing Analysis
    • 12.17.2. Market Share Analysis, 2024
      • 12.17.2.1. By Drug Type
  • 12.18. UAE
    • 12.18.1. Pricing Analysis
    • 12.18.2. Market Share Analysis, 2024
      • 12.18.2.1. By Drug Type
  • 12.19. Israel
    • 12.19.1. Pricing Analysis
    • 12.19.2. Market Share Analysis, 2024
      • 12.19.2.1. By Drug Type

13. Market Structure Analysis

  • 13.1. Competition Dashboard
  • 13.2. Competition Benchmarking
  • 13.3. Market Share Analysis of Top Players
    • 13.3.1. By Regional
    • 13.3.2. By Drug Type

14. Competition Analysis

  • 14.1. Competition Deep Dive
    • 14.1.1. Quest Diagnostics, Inc.
      • 14.1.1.1. Overview
      • 14.1.1.2. Product Portfolio
      • 14.1.1.3. Profitability by Market Segments
      • 14.1.1.4. Sales Footprint
      • 14.1.1.5. Strategy Overview
        • 14.1.1.5.1. Marketing Strategy
    • 14.1.2. Abbott Laboratories
      • 14.1.2.1. Overview
      • 14.1.2.2. Product Portfolio
      • 14.1.2.3. Profitability by Market Segments
      • 14.1.2.4. Sales Footprint
      • 14.1.2.5. Strategy Overview
        • 14.1.2.5.1. Marketing Strategy
    • 14.1.3. Clinical Reference Laboratory, Inc.
      • 14.1.3.1. Overview
      • 14.1.3.2. Product Portfolio
      • 14.1.3.3. Profitability by Market Segments
      • 14.1.3.4. Sales Footprint
      • 14.1.3.5. Strategy Overview
        • 14.1.3.5.1. Marketing Strategy
    • 14.1.4. Laboratory Corporation of America Holdings
      • 14.1.4.1. Overview
      • 14.1.4.2. Product Portfolio
      • 14.1.4.3. Profitability by Market Segments
      • 14.1.4.4. Sales Footprint
      • 14.1.4.5. Strategy Overview
        • 14.1.4.5.1. Marketing Strategy
    • 14.1.5. Cordant Health Solutions
      • 14.1.5.1. Overview
      • 14.1.5.2. Product Portfolio
      • 14.1.5.3. Profitability by Market Segments
      • 14.1.5.4. Sales Footprint
      • 14.1.5.5. Strategy Overview
        • 14.1.5.5.1. Marketing Strategy
    • 14.1.6. Legacy Medical Services, LLC.
      • 14.1.6.1. Overview
      • 14.1.6.2. Product Portfolio
      • 14.1.6.3. Profitability by Market Segments
      • 14.1.6.4. Sales Footprint
      • 14.1.6.5. Strategy Overview
        • 14.1.6.5.1. Marketing Strategy
    • 14.1.7. DrugScan
      • 14.1.7.1. Overview
      • 14.1.7.2. Product Portfolio
      • 14.1.7.3. Profitability by Market Segments
      • 14.1.7.4. Sales Footprint
      • 14.1.7.5. Strategy Overview
        • 14.1.7.5.1. Marketing Strategy
    • 14.1.8. Omega Laboratories, Inc.
      • 14.1.8.1. Overview
      • 14.1.8.2. Product Portfolio
      • 14.1.8.3. Profitability by Market Segments
      • 14.1.8.4. Sales Footprint
      • 14.1.8.5. Strategy Overview
        • 14.1.8.5.1. Marketing Strategy
    • 14.1.9. Psychemedics Corporation
      • 14.1.9.1. Overview
      • 14.1.9.2. Product Portfolio
      • 14.1.9.3. Profitability by Market Segments
      • 14.1.9.4. Sales Footprint
      • 14.1.9.5. Strategy Overview
        • 14.1.9.5.1. Marketing Strategy
    • 14.1.10. Mayo Clinic Laboratories
      • 14.1.10.1. Overview
      • 14.1.10.2. Product Portfolio
      • 14.1.10.3. Profitability by Market Segments
      • 14.1.10.4. Sales Footprint
      • 14.1.10.5. Strategy Overview
        • 14.1.10.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodology